Go Pro

Prelude Therapeutics (PRLD) Institutional Ownership

Prelude Therapeutics logo
$3.67 -0.12 (-3.17%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$3.66 0.00 (-0.14%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Prelude Therapeutics (NASDAQ:PRLD)

Current
Institutional Ownership
Percentage
79.72%
Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$23.89M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$4.22M
Get PRLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PRLD Institutional Buying and Selling by Quarter

Prelude Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Squarepoint Ops LLC59,540$317K0.0%N/A0.075%
9/8/2026Spark Investment Management LLC10,600$56K0.1%N/A0.013%
8/17/2026Bank of America Corp DE23,875$127K0.0%N/A0.030%
8/14/2026ADAR1 Capital Management LLC900,900$4.80M0.2%N/A1.131%
8/14/2026Hsbc Holdings PLC13,652$74K0.0%N/A0.017%
8/13/2026Connor Clark & Lunn Investment Management Ltd.125,606$669K0.0%N/A0.158%
8/7/2026BlackRock Inc.1,797,501$9.58M0.0%N/A2.257%
8/7/2026Deutsche Bank AG27,824$148K0.0%N/A0.035%
8/6/2026Bank of New York Mellon Corp68,187$363K0.0%N/A0.086%
8/6/2026State of Wyoming32,862$175K0.0%N/A0.041%
8/6/2026GSA Capital Partners LLP12,672$68K0.0%N/A0.016%
5/19/2026Bank of America Corp DE56,525$193K0.0%+476.3%0.090%
5/18/2026ADAR1 Capital Management LLC152,825$523K0.0%N/A0.243%
5/18/2026EcoR1 Capital LLC947,049$3.24M0.1%N/A1.503%
5/15/2026OMERS ADMINISTRATION Corp32,700$112K0.0%-55.2%0.052%
5/14/2026Renaissance Technologies LLC275,200$941K0.0%+1.4%0.437%
5/7/2026Dimensional Fund Advisors LP35,210$120K0.0%N/A0.056%
2/18/2026XTX Topco Ltd50,159$145K0.0%+222.0%0.080%
2/18/2026Sphera Funds Management LTD.122,752$356K0.1%N/A0.195%
2/18/2026Millennium Management LLC150,997$438K0.0%-86.8%0.240%
2/17/2026Price T Rowe Associates Inc. MD755,956$2.19M0.0%-13.7%1.202%
2/16/2026OMERS ADMINISTRATION Corp73,000$212K0.0%N/A0.116%
2/13/2026Marshall Wace LLP273,883$794K0.0%N/A0.436%
2/13/2026State Street Corp127,292$369K0.0%+30.4%0.202%
2/12/2026Jane Street Group LLC111,040$322K0.0%+218.9%0.177%
2/12/2026Renaissance Technologies LLC271,300$787K0.0%-50.1%0.432%
2/10/2026Goldman Sachs Group Inc.117,477$341K0.0%+48.1%0.187%
2/9/2026Geode Capital Management LLC272,886$792K0.0%+25.4%0.434%
11/17/2025Millennium Management LLC1,147,044$1.65M0.0%+361.7%1.824%
11/14/2025Shay Capital LLC100,000$144K0.0%+33.3%0.177%
11/14/2025Bridgeway Capital Management LLC53,500$77K0.0%-39.5%0.095%
11/7/2025Vanguard Group Inc.992,854$1.43M0.0%+6.5%1.754%
8/15/2025Shay Capital LLC75,000$61K0.0%N/A0.133%
8/14/2025Jane Street Group LLC91,753$74K0.0%N/A0.163%
8/13/2025Marshall Wace LLP41,747$34K0.0%N/A0.074%
8/12/2025XTX Topco Ltd42,573$34K0.0%+72.4%0.075%
8/8/2025Geode Capital Management LLC217,568$176K0.0%-46.3%0.385%
8/1/2025Y Intercept Hong Kong Ltd47,788$39K0.0%N/A0.085%
5/21/2025Acadian Asset Management LLC529,327$405K0.0%+9.1%0.938%
5/16/2025AQR Capital Management LLC33,823$26K0.0%+170.7%0.078%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
5/12/2025Simplex Trading LLC41,846$32K0.0%+121.2%0.096%
5/9/2025Deutsche Bank AG80,723$62K0.0%-34.8%0.185%
2/17/2025Two Sigma Investments LP231,839$296K0.0%+307.2%0.421%
2/17/2025Two Sigma Advisers LP300,000$382K0.0%+526.3%0.545%
2/17/2025Millennium Management LLC462,555$590K0.0%+188.2%0.841%
2/17/2025Jacobs Levy Equity Management Inc.666,574$850K0.0%+280.9%1.211%
2/17/2025Deutsche Bank AG123,899$159K0.0%+747.6%0.225%
2/17/2025Bridgeway Capital Management LLC111,000$142K0.0%-37.0%0.202%
2/17/2025BNP Paribas Financial Markets20,572$26K0.0%N/A0.037%
2/14/2025Boxer Capital Management LLC1,708,187$2.18M0.2%N/A3.104%
2/14/2025Northern Trust Corp83,387$106K0.0%-21.6%0.152%
2/14/2025Price T Rowe Associates Inc. MD1,029,199$1.31M0.0%-6.2%1.870%
2/13/2025Marshall Wace LLP392,155$498K0.0%+9.2%0.713%
2/13/2025Renaissance Technologies LLC634,500$809K0.0%+222.2%1.153%
2/12/2025Massachusetts Financial Services Co. MA494,497$630K0.0%-10.0%0.899%
2/12/2025JPMorgan Chase & Co.61,149$78K0.0%+925.0%0.111%
2/6/2025Charles Schwab Investment Management Inc.117,200$149K0.0%-12.0%0.213%
1/30/2025Rhumbline Advisers166,830$213K0.0%+1,289.8%0.303%
11/19/2024Barclays PLC27,165$57K0.0%+86.0%0.049%
11/16/2024Geode Capital Management LLC391,716$811K0.0%+8.2%0.712%
11/15/2024Barclays PLC27,165$57K0.0%+86.0%0.049%
11/15/2024XTX Topco Ltd48,239$100K0.0%N/A0.088%
11/15/2024State Street Corp286,046$592K0.0%+35.1%0.520%
11/15/2024Jacobs Levy Equity Management Inc.174,979$362K0.0%+885.2%0.318%
11/14/2024Walleye Capital LLC83,175$172K0.0%+446.2%0.151%
11/12/2024Massachusetts Financial Services Co. MA549,530$1.14M0.0%+5.2%0.999%
10/10/2024Exchange Traded Concepts LLC64,409$133K0.0%+32.2%0.153%
8/15/2024The Manufacturers Life Insurance Company70,045$267K0.0%-3.1%0.166%
8/9/2024Renaissance Technologies LLC206,600$787K0.0%-15.6%0.491%
8/9/2024Dimensional Fund Advisors LP29,074$111K0.0%+103.2%0.069%
8/9/2024Massachusetts Financial Services Co. MA522,375$1.99M0.0%+2.8%1.241%
7/26/2024Bank of New York Mellon Corp36,276$138K0.0%-9.5%0.086%
5/16/2024Kennedy Capital Management LLC25,035$119K0.0%N/A0.059%
5/15/2024Price T Rowe Associates Inc. MD941,971$4.47M0.0%-9.7%2.239%
5/10/2024Acadian Asset Management LLC22,110$104K0.0%+42.7%0.053%
5/10/2024Vanguard Group Inc.1,016,999$4.82M0.0%+1.0%2.417%
2/15/2024Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684%
2/14/2024Pale Fire Capital SE63,581$271K0.0%+106.6%0.116%
1/12/2024SG Americas Securities LLC13,100$56K0.0%N/A0.024%
1/5/2024Exchange Traded Concepts LLC44,087$188K0.0%+34.0%0.080%
11/14/2023Pale Fire Capital SE30,781$95K0.0%N/A0.056%
11/13/2023FMR LLC5,131,433$15.86M0.0%-13.6%9.359%
11/7/2023Barclays PLC13,316$42K0.0%+120.0%0.024%
10/27/2023TD Asset Management Inc160,652$496K0.0%+100.0%0.293%
10/18/2023Exchange Traded Concepts LLC32,907$102K0.0%+29.4%0.060%
9/21/2023Barclays PLC6,052$27K0.0%-41.4%0.011%
8/15/2023Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552%
8/9/2023TD Asset Management Inc80,326$361K0.0%+182.4%0.147%
7/20/2023Exchange Traded Concepts LLC25,428$114K0.0%N/A0.053%
5/16/2023Boxer Capital LLC699,047$3.99M0.2%N/A1.458%
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)

A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel

Click here to learn this company's name for free today
5/1/2023Virtu Financial LLC11,201$64K0.0%N/A0.023%
2/14/2023683 Capital Management LLC28,631$173K0.0%N/A0.060%
2/13/2023GSA Capital Partners LLP47,801$289K0.0%-11.8%0.100%
2/10/2023New York Life Investment Management LLC82,000$495K0.0%+11.7%0.171%
2/9/2023Citigroup Inc.60,072$363K0.0%+604.1%0.126%
2/7/2023Bleakley Financial Group LLC22,325$135K0.0%N/A0.047%
11/15/2022Caxton Associates LP85,992$568K0.1%+2.5%0.180%
11/14/2022PDT Partners LLC12,641$84K0.0%-71.1%0.026%
11/9/2022Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073%
10/25/2022Denali Advisors LLC8,200$54K0.0%N/A0.017%


PRLD Institutional Ownership - Frequently Asked Questions

During the previous two years, 44 institutional investors and hedge funds held shares of Prelude Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($9.58M), ADAR1 Capital Management LLC ($4.80M), EcoR1 Capital LLC ($3.24M), Price T Rowe Associates Inc. MD ($2.19M), Boxer Capital Management LLC ($2.18M), Vanguard Group Inc. ($1.43M), and Renaissance Technologies LLC ($941K).Learn more on Prelude Therapeutics' institutional investors.

79.72% of Prelude Therapeutics' stock is owned by institutional investors. Learn more on PRLD's institutional investor holdings.

Of the 40 institutional investors that purchased Prelude Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($1.80M), Boxer Capital Management LLC ($1.71M), Millennium Management LLC ($1.20M), ADAR1 Capital Management LLC ($1.05M), EcoR1 Capital LLC ($947.05K), Jacobs Levy Equity Management Inc. ($648.81K), and Renaissance Technologies LLC ($441.50K).

Institutional investors have bought a total of 5,946,427 shares in the last 24 months. This purchase volume represents approximately $23.89M in transactions.

The following institutional investors have sold Prelude Therapeutics stock in the last 24 months: Millennium Management LLC ($996.05K), Renaissance Technologies LLC ($272.70K), Price T Rowe Associates Inc. MD ($120.38K), OMERS ADMINISTRATION Corp ($40.30K), and Bridgeway Capital Management LLC ($35K).

Institutional investors have sold a total of 1,464,429 shares in the last 24 months. This volume of shares sold represents approximately $4.22M in transactions.



Institutional ownership data for NASDAQ:PRLD is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners